Drug Shortage Report for GABAPENTIN
| Report ID | 280502 |
| Drug Identification Number | 02432080 |
| Brand name | GABAPENTIN |
| Common or Proper name | Gabapentin Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| Anatomical Therapeutical Chemical (ATC) code | N02BF |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-04-30 |
| Actual start date | |
| Estimated end date | 2026-05-29 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-13 | French | Compare |
| v1 | 2026-03-13 | English | Compare |
Showing 1 to 2 of 2